- Microdosing psychedelics appears to influence psychological pathways instead of directly enhancing neurocognitive performance.
- The research found no significant links between microdosing days and cognitive performance across various functions, suggesting that subjective enhancements in performance may not be reflected in measurable cognitive improvements.
- Remote testing methods employed in this study allow for capturing cognitive performance in naturalistic settings across diverse demographics, potentially offering benefits for future longitudinal research.
Introduction to the Study
The researchers conducted an observational study involving 17 participants who were monitored during their microdosing routines with psychedelics such as psilocybin and LSD. This study utilized the CNSVS neurocognitive battery in a naturalistic environment to assess cognitive performance multiple times throughout the microdosing regimen. Anecdotal evidence often suggests that microdosing enhances cognitive and emotional functioning; however, the authors aimed to investigate whether these claims hold true in a structured and controlled manner.
Findings on Cognitive Performance
Overall, the results indicated that there were no significant differences in cognitive functions, such as processing speed, attention, and memory, either on the days of microdosing or the days following. This lack of measurable improvement suggests that any perceived enhancement in performance may originate from psychological factors, such as the placebo effect, rather than genuine improvements in cognitive processing. The findings challenge the common belief in substantial cognitive benefits arising from microdosing practices.
Methodology: How the Study Was Conducted
The data collection occurred over 28 days with participants self-reporting their microdosing habits through questionnaires. Cognitive function was evaluated using the CNSVS battery, comprising various tasks to assess processing speed, attention, executive functions, and memory. Throughout the study, participants conducted between four to sixteen assessments, allowing for an in-depth analysis of microdosing effects on cognitive performance.
Insights on Psychological vs. Neurocognitive Effects
Despite not finding measurable improvements in cognitive function, the authors noted the psychological impacts of microdosing, which might contribute to participants’ feelings of enhanced performance. They suggested that such effects could stem from individual differences in expectation or mindset rather than actual neurocognitive enhancements. This highlights the complex interplay between subjective experience and objective cognitive assessments.
Implications for Future Research
The study presents several limitations, including the absence of placebo controls and the small sample size, which could interfere with the reliability of the findings. Nevertheless, the adoption of remote testing methods allowed the researchers to conduct the study in a more flexible manner, accommodating participants across different time zones and individual schedules. Future research could build upon these methods to explore the nuanced effects of psychedelics within varied population samples, thereby enriching the understanding of microdosing’s role across cultures and contexts.
Read the full paper summary on Blossom.
